全文获取类型
收费全文 | 17631篇 |
免费 | 1396篇 |
国内免费 | 423篇 |
专业分类
耳鼻咽喉 | 2072篇 |
儿科学 | 380篇 |
妇产科学 | 320篇 |
基础医学 | 1382篇 |
口腔科学 | 231篇 |
临床医学 | 1726篇 |
内科学 | 1752篇 |
皮肤病学 | 139篇 |
神经病学 | 2891篇 |
特种医学 | 278篇 |
外科学 | 1797篇 |
综合类 | 2104篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 1540篇 |
眼科学 | 170篇 |
药学 | 1432篇 |
24篇 | |
中国医学 | 697篇 |
肿瘤学 | 513篇 |
出版年
2024年 | 74篇 |
2023年 | 349篇 |
2022年 | 584篇 |
2021年 | 819篇 |
2020年 | 859篇 |
2019年 | 826篇 |
2018年 | 719篇 |
2017年 | 723篇 |
2016年 | 763篇 |
2015年 | 648篇 |
2014年 | 1227篇 |
2013年 | 1507篇 |
2012年 | 968篇 |
2011年 | 1098篇 |
2010年 | 836篇 |
2009年 | 846篇 |
2008年 | 919篇 |
2007年 | 857篇 |
2006年 | 731篇 |
2005年 | 606篇 |
2004年 | 536篇 |
2003年 | 428篇 |
2002年 | 339篇 |
2001年 | 281篇 |
2000年 | 247篇 |
1999年 | 193篇 |
1998年 | 164篇 |
1997年 | 166篇 |
1996年 | 129篇 |
1995年 | 122篇 |
1994年 | 110篇 |
1993年 | 75篇 |
1992年 | 78篇 |
1991年 | 60篇 |
1990年 | 70篇 |
1989年 | 54篇 |
1988年 | 54篇 |
1987年 | 46篇 |
1986年 | 42篇 |
1985年 | 53篇 |
1984年 | 43篇 |
1983年 | 24篇 |
1982年 | 38篇 |
1981年 | 32篇 |
1980年 | 25篇 |
1979年 | 20篇 |
1978年 | 20篇 |
1977年 | 17篇 |
1976年 | 6篇 |
1974年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies 下载免费PDF全文
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献
2.
《Journal of vascular and interventional radiology : JVIR》2020,31(3):378-387
PurposeTo determine if cone-beam CT and digital subtraction angiography analysis of pelvic arterial anatomy has predictive value for radiation exposure and technical success of prostatic artery embolization (PAE).Materials and MethodsThis prospective, nonrandomized, single-center study included 104 consecutive patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Cone-beam CT was performed in 160/208 (76.9%) hemipelves to determine prostatic artery (PA) origin. Classification of pelvic arterial tortuosity was possible in 73/104 (70.2%) patients. Learning curves of 2 interventionalists who performed 86.5% of PAEs were analyzed.ResultsTortuosity of pelvic arteries was classified as mild in 25 (34.2%) patients median age 64 years, moderate in 40 (54.8%) patients median age 69 years, and severe in 8 (11.0%) patients median age 70 years (mild vs moderate, P = .002; mild vs severe, P = .019); median fluoroscopy times were 24, 36, and 46 minutes (P = .008, P = .023); median contrast volumes were 105, 122.5, and 142 mL (P = .029, P = .064); and bilateral PAE rates were 84.0%, 77.5%, and 62.5% (P = .437), respectively. PA origin from superior vesical artery was most frequent (27.5%) and showed higher dose area product (median 402.4 vs 218 Gy ∙ cm2, P = .033) and fluoroscopy time (median 42.5 vs 27 min, P = .01) compared with PA origin from obturator artery, which was least frequent. Interventionalist experience revealed significant impact on procedure times (median 159 vs 130 min, P = .006).ConclusionsTortuosity of pelvic arteries was more frequent in older patients and predicted worse technical outcomes of PAE. PA origin from obturator artery was associated with lower dose area product and fluoroscopy time, especially compared with PA origin from superior vesical artery. Interventionalist experience showed significant influence on technical outcome. 相似文献
3.
4.
5.
目的:分析鼻塞式同步间歇正压通气(NIPPV)联合布地奈德雾化治疗ARDS(新生儿急性呼吸窘迫综合征)疾病的临床应用效果。方法:纳入病例是2017年5月—2019年11月收治的104例ARDS新生儿,随机平均分为两组。参照组52例采纳CPAP(持续气道正压通气通气)治疗,实验组52例采纳NIPPV+布地奈德雾化治疗,对比两组呼吸机通气时间、用氧时间、住院时间、血气指标以及并发症发生情况。结果:实验组呼吸机通气时间、用氧时间、住院时间均明显短于参照组,差异有统计学意义P<0.05;实验组治疗3 d后PaCO2明显低于参照组,实验组治疗3 d后PH以及PaO2明显高于参照组,差异有统计学意义P<0.05;实验组并发症发生率(3.85%,2/52)明显低于参照组(21.15%,11/52),差异有统计学意义P<0.05。结论:NIPPV+布地奈德雾化可有效缩短ARDS患者机械通气时间,改善血气指标,降低并发症发生率,值得借鉴。 相似文献
6.
7.
8.
Fur-Hsing Wen Jen-Shi Chen Wen-Chi Chou Wen-Cheng Chang Wen Chi Shen Chia-Hsun Hsieh Siew Tzuh Tang 《Journal of pain and symptom management》2019,57(1):64-72
Context
Family caregivers constitute a critical component of the end-of-life care system with considerable cost to themselves. However, the joint association of terminally ill cancer patients' symptom distress and functional impairment with caregivers' subjective caregiving burden, quality of life (QOL), and depressive symptoms remains unknown.Objectives/Methods
We used multivariate hierarchical linear modeling to simultaneously evaluate associations between five distinct patterns of conjoint symptom distress and functional impairment (symptom-functional states) and subjective caregiving burden, QOL, and depressive symptoms in a convenience sample of 215 family caregiver–patient dyads. Data were collected every 2 to 4 weeks over patients' last 6 months.Results
Caregivers of patients in the worst symptom-functional states (States 3–5) reported worse subjective caregiving burden and depressive symptoms than those in the best two states, but the three outcomes did not differ between caregivers of patients in State 3 and States 4–5. Caregivers of patients in State 5 endured worse subjective caregiving burden and QOL than those in State 4. Caregivers of patients in State 4 suffered worse subjective caregiving burden and depressive symptoms but comparable QOL to those in State 2.Conclusion
Patients' five distinct, conjoint symptom-functional states were significantly and differentially associated with their caregivers' worse subjective caregiving burden, QOL, and depressive symptoms while caring for patients over their last 6 months. 相似文献9.
鼻部源性突眼的CT分析 总被引:1,自引:0,他引:1
目的:为了提高对鼻部源性突眼的认识。材料和方法:本文19例鼻部源性突眼,其中鼻咽癌7例,鼻咽纤维血管瘤2例,鼻腔纤维血管瘤、恶性肉芽肿和嗅神经母细胞瘤各1例,上颌窦癌和软骨肉瘤各2例,上颌窦恶性肉芽肿、纤维肉瘤和恶性纤维组织细胞瘤各1例,全部病例均作轴位CT扫描,12例加作增强扫描,详细分析了它们CT表现。结果:源于鼻咽的放疗前鼻咽癌和纤维血管瘤,其病变主要位于鼻咽腔和咽旁,后者显著增强并有钙斑,与前者不同;源于上颌窦的肿瘤,病变占据上颌窦的全部或大部分,软骨肉瘤有钙斑且无强化,易与其它肿瘤区别,它们破坏上颌窦顶部进入眼眶;鼻腔嗅神经母细胞瘤在鼻腔和筛窦形成肿块,破坏筛骨眶板侵入眼眶。结论:根据CT所见,可判断突眼原因。 相似文献
10.